Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Physiology. Endocrinology and Metabolism|January 11, 2007
Angiotensin II increases adipose angiotensinogen expressionHong Lu, Carine M Boustany-Kari, Alan Daugherty, et al.
Biomedical Chromatography : BMC|November 13, 2009
Quantitative sphingosine measurement as a surrogate for total ceramide concentration-preclinical and potential translational applicationsErick Kindt, John Wetterau, Sandra Bak Mueller, et al.
European Journal of Pharmacology|March 5, 2011
Leptin potentiates the anti-obesity effects of rimonabantCarine M Boustany-Kari, V Margaret Jackson, Colleen P Gibbons, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 31, 2012
Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 miceManisha Gupte, Sean E Thatcher, Carine M Boustany-Kari, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 25, 2008
ACE2 is expressed in mouse adipocytes and regulated by a high-fat dietManisha Gupte, Carine M Boustany-Kari, Kalyani Bharadwaj, et al.
Journal of Translational Medicine|October 25, 2011
The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonismRena J Eudy, Vaishali Sahasrabudhe, Kevin Sweeney, et al.
Frontiers in Pharmacology|October 18, 2013
PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathyStephen Orena, Tristan S Maurer, Li She, et al.
Journal of the American Society of Nephrology : JASN|June 2, 2019
Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 DiabetesHelen C Looker, Michael Mauer, Pierre-Jean Saulnier, et al.
The AAPS Journal|August 27, 2011
Pharmacodynamic model of sodium-glucose transporter 2 (SGLT2) inhibition: implications for quantitative translational pharmacologyTristan S Maurer, Avijit Ghosh, Nahor Haddish-Berhane, et al.
Kidney International|October 22, 2017
A molecular morphometric approach to diabetic kidney disease can link structure to function and outcomeViji Nair, Claudiu V Komorowsky, E Jennifer Weil, et al.
Pageof 3